Abstract
Keywords
Liver Neoplasms Fibromodulin Signaling Pathway NF-kappa B Transforming Growth Factor beta سرطانهای کبد فیبرومودلین مسیر پیامرسانی NF-kappa B ﻋﺎﻣﻞ ﺑﺘﺎﻱ ﺭﺷﺪ ﻣﺘﻐﻴﺮ
References
-
1.
Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep 2019; 6: 104-111.
-
2.
Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer 2018; 124: 2785-2800.
-
3.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7-34.
-
4.
Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 2019; 156: 477-491.
-
5.
Endeshaw M, Hallowell BD, Razzaghi H, Senkomago V, McKenna MT, Saraiya M. Trends in liver cancer mortality in the United States: Dual burden among foreignand USborn persons. Cancer. 2019;125(5):726-34.
-
6.
Scheller EL, Krebsbach PH. Gene therapy: design and prospects for craniofacial regeneration. J Dent Res 2009; 88: 585-596.
-
7.
Dawoody Nejad L, Biglari A, Annese T, Ribatti D. Recombinant fibromodulin and decorin effects on NF-B and TGF1 in the 4T1 breast cancer cell line. Oncol Lett 2017; 13: 4475-4480.
-
8.
Baghy K, Ttrai P, Regs E, Kovalszky I. Proteoglycans in liver cancer. World J Gastroenterol 2016; 22: 379.
-
9.
Gold LI. The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 1999; 10: 303-360.
-
10.
Poniatowski A, Wojdasiewicz P, Gasik R, Szukiewicz D. Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. Mediators Inflamm 2015; 2015: 137823.
-
11.
Neuzillet C, de Gramont A, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S, Raymond E. Perspectives of TGF- inhibition in pancreatic and hepatocellular carcinomas. Oncotarget 2014; 5: 78.
-
12.
Tian M, Neil JR, Schiemann WP. Transforming growth factor-beta and the hallmarks of cancer. Cell Signal 2011; 23: 951-962.
-
13.
Gao J, Xu HL, Gao S, Zhang W, Tan YT, Rothman N, et al. Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested casecontrol study in Shanghai, China. BMJ Open 2014; 4: e004427.
-
14.
Xia Y, Shen S, Verma IM. NF-B, an active player in human cancers. Cancer Immunol Res 2014; 2: 823-830.
-
15.
Park MH, Hong JT. Roles of NF-B in cancer and inflammatory diseases and their therapeutic approaches. Cells 2016; 5.
-
16.
Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: a001651.
-
17.
Mossanen JC, Tacke F. Role of lymphocytes in liver cancer. Oncoimmunology 2013; 2: e26468.
-
18.
Pourhanifeh MH, Mohammadi R, Noruzi S, Hosseini SA, Fanoudi S, Mohamadi Y, et al. The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy. Cancer Cell Int 2019; 19: 157.
-
19.
Mormone E, Lu Y, Ge X, Fiel MI, Nieto N. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice. Gastroenterology 2012; 142: 612-621.e5.
-
20.
Baghy K, Ttrai P, Regs E, Kovalszky I. Proteoglycans in liver cancer. World J Gastroenterol 2016; 22: 379-393.
-
21.
Morn A, Bellomo C, Tsubakihara Y, Kardassis D, Mikulits W, Heldin CH, Moustakas A. LXR limits TGF-dependent hepatocellular carcinoma associated fibroblast differentiation. Oncogenesis 2019; 8: 36.
-
22.
Jia M, Souchelnytskyi S. Comments on the cross-talk of TGF and EGF in cancer. Exp Oncol 2011; 33: 170-173.
-
23.
Luedde T, Schwabe RF. NF-B in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2011; 8: 108-118.
-
24.
Lee YH, Schiemann WP. Fibromodulin suppresses nuclear factor-b activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosis. J Biol Chem 2011; 286: 6414-6422.
-
25.
Jazi MF, Biglari A, Mazloomzadeh S, Kingston P, Ramazani A, Bazzaz JT, Eskandari M. Recombinant fibromodulin has therapeutic effects on diabetic nephropathy by down-regulating transforming growth factor-1 in streptozotocin-induced diabetic rat model. Iran J Basic Med Sci 2016; 19: 265-271.